Verastem Q2 Adj $(0.61) Beats $(0.95) Estimate, Sales $10.00K Miss $50.00K Estimate
Portfolio Pulse from Benzinga Newsdesk
Verastem (NASDAQ:VSTM) reported Q2 adjusted losses of $(0.61) per share, beating the analyst estimate of $(0.95) by 35.79%. However, the company missed sales estimates, reporting $10.00K in sales versus the expected $50.00K.
August 08, 2024 | 9:18 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Verastem's Q2 adjusted losses of $(0.61) per share beat analyst estimates by 35.79%, but the company missed sales estimates significantly, reporting $10.00K in sales versus the expected $50.00K.
While Verastem's earnings per share beat expectations significantly, the substantial miss on sales estimates could offset the positive sentiment. Investors may have mixed reactions, leading to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100